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Identification of Local Recurrence and Radiofibrosis by Computed
Tomography Perfusion on Nasopharyngeal Carcinoma After Radiotherapy
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aCenter of Image, Oncology Hospital, Guangxi Medical University, Nanning, Guangxi, P.R. China
bDepartment of Pediatrics, Guangxi Medical University, Nanning, Guangxi, P.R. ChinaAbstractPurpose: The aim of this study was to investigate the role of perfusion computed tomography (CT) for identification of local recurrence (LR)
and radiofibrosis (RF) in patients with nasopharyngeal carcinoma after radiotherapy.
Methods: Forty-eight prospective patients were recruited for this study. NPC diagnosis was confirmed by pathologic biopsy examination.
Immunohistochemistry staining was used on biopsy specimens, and microvessel density was calculated by microscopy. Perfusion CT was
performed on both the LR group (n ¼ 31) and the RF group (n ¼ 17) after intravenous injection of contrast medium. Time-density curve,
blood flow, blood volume, and mean transit time, as well as permeability surface area product, were analyzed as perfusion CT parameters.
The microvessel density was compared between both the LR and RF groups.
Results: There is a significant difference between the LR and RF groups in microvessel density, the time density curve, blood flow blood
volume, mean transit time, and the permeability surface area product (P < .01).
Conclusions: The results demonstrate that perfusion CT is a reliable and accurate method to identify LR and RF after radiotherapy in patients
with nasopharyngeal carcinoma.Re´sume´Objet: Cette e´tude visait a` de´terminer le roˆle de la tomodensitome´trie avec perfusion dans la de´tection de la re´cidive locale et de la radi-
ofibrose chez les patients atteints de carcinome du nasopharynx, apre`s traitement de radiothe´rapie.
Me´thodes: Quarante-huit patients potentiels ont e´te´ recrute´s pour cette e´tude. Le diagnostic de carcinome du nasopharynx a e´te´ confirme´ par
biopsie. Les tissus pre´leve´s par biopsie ont e´te´ soumis a` une coloration immunohistochimique, et la densite´ des microvaisseaux a e´te´ calcule´e
par microscopie. Les patients du groupe de re´cidive locale (n ¼ 31) et ceux du groupe de radiofibrose (n ¼ 17) ont be´ne´ficie´ d’une
tomodensitome´trie avec perfusion avec injection intraveineuse de produit de contraste. La courbe temps-densite´, le de´bit et le volume
sanguin, le temps de circulation moyen, ainsi que le produit perme´abilite´-surface ont e´te´ analyse´s a` titre de parame`tres de la tomodensi-
tome´trie avec perfusion. La densite´ des microvaissaux a e´te´ compare´e entre les patients du groupe de re´cidive locale et ceux du groupe de
radiofibrose.
Re´sultats: Il existe une diffe´rence significative entre le groupe de re´cidive locale et celui de radiofibrose en ce qui concerne la densite´ des
microvaisseaux, la courbe temps-densite´, le de´bit et le volume sanguins, le temps de circulation moyen et le produit perme´abilite´-surface
(P < 0,01).
Conclusions: Les re´sultats de´montrent que la tomodensitome´trie avec perfusion est une me´thode fiable et pre´cise afin de de´tecter la re´cidive
locale et la radiofibrose suite a` une radiothe´rapie chez les patients atteints de carcinome du nasopharynx.
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doi:10.1016/j.carj.2009.11.009Nasopharyngeal carcinoma (NPC) is a type of malignancy in
the head and neck region that is endemic and is an Epstein-Barr
viruserelated cancer [1]. It is one of the most common cancersll rights reserved.
266 D. Su et al. / Canadian Association of Radiologists Journal 61 (2010) 265e270in the southern China. In the Guangxi province, the incidence of
NPC is about 4.7 in 100,000 of the population [2]. NPC is
mainly radiosensitive, and radiotherapy (RT) is still the standard
treatment for NPC. But in nearly 7%e13% of NPC cases,
residual disease persists after treatment. Tumour recurrence is
usually first visualized by nasopharyngoscopy, then imaging
studies follow to assess tumour extent, and finally the confir-
mation is made by biopsy. Imaging studies are also used to
confirm deep recurrences that are not apparent at nasophar-
yngoscopy based on the patient’s history and symptoms.
Hopefully, an accurate noninvasive method, which can distin-
guish between the local recurrence and the radiofibrosis, would
be available.
Perfusion computed tomography (CT) is a technique that
allows quantitative assessment of various hemodynamic
parameters, such as tumour blood flow (BF), blood volume
(BV), mean transit time (MTT), and permeability surface
area product (PS). Several reports [3e6] discuss the use of
perfusion CT for tumours located in the brain as well as in
the head and neck. The purpose of our current study was to
prospectively assess the perfusion CT for distinction between
the LR and the RF in patient with NPC after RT.
Materials and Methods
This study was approved by the institutional review board
of Oncology Hospital, Guangxi Medical University;
informed patient consent was obtained. From January 2005
to June 2007, a total of 48 patients were enrolled when the
following criteria were met: (1) LR of NPC and RF were
confirmed by pathologic examination and the diameter of
lesion was larger than 2 cm, and (2) the patient’s renal and
liver function tests were within the normal range. The cohort
study included 28 men and 20 women (age range, 30e66
years; mean age, 46.33 years) with a biting biopsye
confirmed diagnosis of LR or RF. The patients were divided,
according to final diagnosis, into 2 groups: LR and RF.
Perfusion CT was performed with an 8-section multi-
detector CT scanner (Light Speed Ultra; GE Medical Systems,
Waukesha, WI). In order to localize the lesion, a CT scan from
the cavernous sinus to the alveolar of the maxillary was
obtained without contrast medium during a breath hold and no
deglutition. A first acquisition (120 kV, 250 mAs) was obtained
without intravenous injection of contrast medium. This helped
to localize the lesion and setting 4 dynamic acquisition slices at
the correct level. After lesion localization, a 2-cm lesion region
was selected independently by the radiologists for the dynamic
study in the maximal diameter of the lesion. Four slices were
selected to cover the lesion as much as possible. A dynamic
study of the selected area was performed at a static table
position. Dynamic images (80 kV, 80 mAs) were taken 5
seconds after starting the contrast-medium injection. A total of
50 mL of nonionic iodinated contrast medium (Ultravist 300;
Schering Guangzhou, China) (300 mg/mL iodine) was injected
at a rate of 4.5 mL/min through an 18-gauge intravenous
syringe. Acquisition lasted for 55.65 seconds, at the rate of
4 images per 0.65 second. A total of 340 images were acquired.Data AnalysisData were prepared and processed at a workstation
(Advantage Windows 4.2; GE Medical Systems) with perfu-
sion CT software (GE Perfusion 3.0) by experienced individ-
uals. Functional maps of time density curve (TDC), BF, BV,
MTT, and PS were generated. The functional maps were
obtained by (1) displaying images at an appropriate window,
such as the soft tissue of the nasopharynx (width ¼ 300 HU,
level ¼ 40 HU), and (2) selecting the external carotid artery
manually as an input artery and the retromandibular vein as an
output vein by placing a region of interest (ROI) (2e6 pixels in
size). ROIs were placed in the external carotid artery without
any mural calcification. ROIs for the lesions were drawn in
anatomic section locations obtained in each patient. It is
important that visible vessels and pathologic zones, such as
necrosis and/or cysts, would be excluded. The size of the ROI
should be at least 50 pixels to minimize the effect of photon
noise and with a sufficient margin to avoid partial volume
effects (Figure 1A). Functional maps were displayed in colours
that ranged from blue to red, blue being the lower range of
display for BF (colour range, 0e400 mL per 100 g per min),
BV (colour range, 0e10 mL per 100 g), and PS (colour range,
0e20 mL per 100 g per min), and red being the lower range of
display for MTT (colour range, 0e15 seconds) (Figure 1B).
This was performed mainly to obtain comparable colour maps.Immunohistochemistry Staining of TissueA frozen section, 5-mm thick, was cut from all samples of
both groups. The primary antibody used was mouse anti-
human CD34þ monoclonal antibody (Zhongshan Biologic
Preparation Co., Guangzhou, China). Vascular hot spots were
screened by using  100 magnification. Each microvessel
was counted by using  200 magnifications. The value was
expressed as the number of microvessels per 0.2 mm2.
Criteria for positive staining and microvessel counting were
the same as described by Weidner [7]. The mean microvessel
density (MVD) values were calculated at 5 hot-spot areas,
including the lesion rim and core regions.Statistical AnalysisStatistics analysis was done with SPSS (version 13) soft-
ware (SPSS Inc., Chicago, IL), and the significant difference
was defined as.05. An independent sample t test was used to
compare the differences in perfusion CT parameters and MVD
between the LR and the RF after RT in patients with NPC.
Results
The time-density curve was compared between the LR
and the RF groups. Different patterns of the time-density
curves were observed; the pattern of the LR group showed
a fast initial rising to peak and slowly descending following
(Figure 2A). However, the time density curve of the RF
group showed a flat curve (Figure 2B).
Figure 1. (A) Transverse contrast materialeenhanced computed tomography (CT) image, and (B) functional perfusion CT colour map of blood flow
demonstrate a technique of perfusion CT in a patient with local recurrence. Various regions of interest in the external carotid artery (1), the retromandibular vein
(2), and the tumour (3) were drawn. Functional colour maps for each perfusion parameter were displayed according to colour scale (large arrow), and average
perfusion values for each region of interest (small arrows) were obtained.
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and RF groups. Regarding the perfusion CT parameters
between the 2 groups, BF, BV, and PS of the LR group were
significantly higher than the RF group (Table 1); MTT of the
LR group was significantly lower than the RF group (Figures
3AeD and 4AeD). This may indicate the high vascularity in
LR. There was a significant statistical difference in all 4
above-mentioned perfusion parameters between the LR and
the RF groups (P < .01).Immunohistochemistry FindingsFrom immunohistochemistry staining, the MVD mean (SD)
value of the LR group (55.68 15.8 mm2) was higher than that
of the RF group (14.45 8.46 mm2) (P< .01). The MVD of theFigure 2. (A) A graph of a 48-year-old woman with local recurrence in posterad
the radiofibrosis shows time-density curves of the external carotid artery (1), theLR varied from 30.2e80.6 per 0.2 mm2. Both clustered and
sparse capillaries could be seen in both groups (Figure 5A, B).
Discussion
The availability of rapid imaging with multidetector CT
systems and commercial analysis software has made perfu-
sion imaging with CT easy to use, not only for the brain but
also for other body organs. Perfusion imaging is usually
performed as an adjunct to a conventional CT examination
and, therefore, is particularly appropriate when a conven-
tional CT is part of routine clinical practice [8]. So far in
oncology, perfusion CT can give an image related to tumour
vascularity, which can differentiate between the benign and
malignant lesions.iation therapy nasopharyngeal carcinoma, and (B) in a 60-year-old man with
retromandibular vein (2), and the lesion (3).
Table 1
Perfusion computed tomography parameters between the local recurrence
and the radiofibrosis groups
Perfusion computed
tomography parameters
Local recurrence
group, mean (SD)
Radiofibrosis
group, mean (SD)
P
value*
Blood flow 405.5920  79.0850 92.7559  58.2506 <.01
Blood volume 16.6887  6.2876 4.8847  2.3575 <.01
Mean transit time 3.2418  1.6392 24.7418  14.9321 <.05
Permeability surface
area product
53.7422  11.5263 14.9675  9.5718 <.01
*A P value of  .05 indicates a significant difference between two groups.
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in malignant lymphoma after comparing the perfusion CT
and pathologic examination. Also, Yeung et al [10] usedFigure 3. (AeD) Transverse perfusion computed tomography functional maps of
product in 48-year-old woman with local recurrence of posteradiation therapy n
volume, 14.548 mL per 100 g; permeability surface area product, 58.924 mL pedynamic CT for assessment of microvascular changes in
tumour progression and demonstrated an increase of CT-
derived BV and permeability that paralleled the advancing
age of VX2 tumours. In rectal cancer, a decrease in tumour
vascularity at perfusion CT after radiation therapy was
associated with a better response to therapy [11]. Results of
another study on rectal cancer established a correlation
between tumour BF at perfusion CT and MVD; those data
indicated that perfusion CT could be used to quantify of
tumor angiogenesis [12]. However, so far, no reports were
found that used perfusion CT and MVD to compare the LR
and the RF in NPC after radiation therapy (RT).
Our preliminary data showed that TDC is a reliable
method to distinguish between the LR and the RF groups. Toblood flow, blood volume, mean transit time, and permeability surface area
asopharyngeal carcinoma, blood flow, 329.41 mL per 100 g/100/min; blood
r 100 g per minute; and mean transit time of 1.6 seconds.
Figure 4. (AeD) Transverse perfusion computed tomography functional maps of blood flow, blood volume, permeability surface area product, and mean transit
time in a 60-year-old man with radiofibrosis. Perfusion values from regions of interest drawn for the lesion (3) (arrow) show blood flow, 83.354 mL per 100 g
per minute; blood volume, 2.1313 mL per 100 g; permeability surface area product, 6.6265 mL per 100 g per minute; and mean transit time, 4 seconds.
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contrast medium uptake and washout in enhancement. Fast-
ascend and slow descend TDC lied in the local recurrence.
‘‘Flat’’ TDCs were observed in the RF group. Our results
were similar to and confirmed that early stage contrast
enhancement is highly suspicious for carcinoma [13]. In
addition, our study indicated that MVDs of the LR group
were higher than those of the RF group (but our studyFigure 5. (A) Capillaries in 48-year-old woman with the local recurrence in post
with radiofibrosis. Photomicrographs show clustered and sparse capillaries. Immuconsidered that the MVD sites by biting biopsy may not
always correspond to the ROI selected, so it did not show the
correlation between the lesions and MVD). Based on the
previous findings of the correlation between the slope and
MVD of tumour [14e18], vascularity may explain why the
rapid increasing of density was only observed in the early
stage of the subjects in the LR group rather than in the RF
group with NPC after RT.eradiation therapy nasopharyngeal carcinoma, and (B) in a 60-year-old man
noreactivity for CD34 is seen in brown. (CD34 stain, magnification  200.)
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values could be used to verify LR with RF. In the LR group,
all of its perfusion CT parameters, such as BF, BV, and PS, as
well as MTT, were significantly difference than the RF
group. Even though the feeding artery of the LR and the RF
is derived from the ascending pharyngeal [19,20], the
vascularity distinction led to the significant difference
between LR and RF. Accordingly, diagnostic imaging is
unable to visualize the local microvessel, but, based on the
correlation between tissue perfusion and vascular construc-
tion, the perfusion CT still could provide reliable information
(such as BV, BF, PS, and MTT) about local microvessels in
specific areas and parameters for distinguishing between the
LR and RF after RT in patients with NPC.
After this study, it is necessary to assess perfusion CT in
different stages of RF, compare the parameters and markers of
angiogenesis in tumour lesions, and examine the replacement
of the external carotid artery by the ascending pharyngeal
artery as an arterial input. Also, a prospective study is neces-
sary to confirm perfusion CT to be routing diagnostic appli-
cation, as perfusion CT may be the extra radio exposure. Our
initial experience suggests that the perfusion CT technique
parameters (BF, BV, PS, and MTT) are useful and reliable to
distinct LR and RF after RT in patients with NPC.
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